Posted inStock
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
By Ahmed Aboulenein and Amina Niasse WASHINGTON (Reuters) -The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including for heart disease, cancer and…